Drug companies gave at least $116 million to patient advocacy groups in 2015, according to a database launched Friday by Kaiser Health News. “Patient advocacy groups campaign to raise awareness of diseases, to fund research and to promote policies favorable to their causes on Capitol Hill and at the Food and Drug Administration,” KHN writes. “But do they represent patients or Big Pharma? Kaiser Health News has compiled and analyzed disclosures to shed light on the flow of money between the pharmaceutical industry and patient advocacy groups. The Pre$cription for Power database will be available for downloading in May. The database currently covers 2015 and will be updated as additional data become available.”

Related News Articles

Headline
The House Energy and Commerce Subcommittee on Health today passed the No Surprises Act (H.R. 3630), bipartisan legislation that would prohibit balance billing…
Headline
President Trump intends to nominate Adam Boehler — senior advisor to the Health and Human Services Secretary, Centers for Medicare…
Headline
The House Energy and Commerce Subcommittee on Health tomorrow is scheduled to mark up 10 health-related bills, including the No Surprises Act — bipartisan…
Headline
The Centers for Medicare…
Headline
Health and Human Services Secretary Alex Azar last week announced that Paul Mango will assume the role of deputy chief of staff for policy, a new position…
Blog
Women in rural areas face unique maternal health care challenges, including hospital closures or lack of obstetric services. In this AHA Stat Blog, Jay Bhatt,…